Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol CMND
- Company Clearmind Medicine Inc.
- Price $1.54
- Changes Percentage -12.25
- Change -0.215
- Day Low $1.53
- Day High $1.78
- Year High $6.8
- Year Low $0.92
- Market Cap $6,246,756
- Price Avg 50 EMA (D) $1.3
- Price Avg 200 EMA (D) $1.37
- Exchange NASDAQ
- Volume 565,390
- Average Volume 385,568
- Open $1.78
- Previous Close $1.76
- EPS -1.23
- PE -1.25
- Earnings Announcement 2023-04-30 04:00:00
- Shares Outstanding $4,056,335
Company brief: CLEARMIND MEDICINE INC. (CMND )
- Healthcare
- Biotechnology
- Dr. Adi Zuloff-Shani Ph.D.
- https://www.clearmindmedicine.com
- CA
- N/A
- 11-15-2022
- CA1850534027
Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.